Literature DB >> 15113362

Review article: The medical treatment of Crohn's perianal fistulas.

D A Schwartz1, C R Herdman.   

Abstract

Perianal fistulas are a frequent manifestation of Crohn's disease. The correct application of the newer diagnostic and therapeutic agents for treating perianal Crohn's disease are beginning to be better defined. In general, a combined medical and surgical approach is preferred. The perianal disease process should first be fully delineated with endoscopy and either MRI or EUS before treatment is begun. Patients are then stratified into one of three groups: simple fistulas and no proctitis; simple fistulas and concomitant proctitis; and complex fistulas. Patients with simple fistulas and no proctitis can be treated medically with a combination of antibiotics and an immunosuppressive agent (azathioprine or mercaptopurine). Patients with simple fistulas and concomitant proctitis should have infliximab added to their treatment plan. Complex fistulas require surgical intervention first prior to medical treatment. A combination of antibiotics, immunosuppressive therapy and infliximab are then initiated to facilitate fistula healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113362     DOI: 10.1111/j.1365-2036.2004.01917.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

Review 1.  Evaluation of perianal fistulas in patients with Crohn's disease.

Authors:  Jennifer Jones; William Tremaine
Journal:  MedGenMed       Date:  2005-05-18

Review 2.  Antibiotic therapy for Crohn's disease: a review.

Authors:  Simon Lal; A Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 3.  Imaging techniques and combined medical and surgical treatment of perianal Crohn's disease.

Authors:  F Botti; A Losco; C Viganò; B Oreggia; M Prati; E Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-24

Review 4.  Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.

Authors:  Julián Panés; Jordi Rimola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-09       Impact factor: 46.802

5.  CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response.

Authors:  Paulo Freire; Francisco Portela; Maria M Donato; Manuela Ferreira; Paulo Andrade; Carlos Sofia
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

Review 6.  Update on anal fistulae: surgical perspectives for the gastroenterologist.

Authors:  Helena Tabry; Paul A Farrands
Journal:  Can J Gastroenterol       Date:  2011-12       Impact factor: 3.522

7.  AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.

Authors:  Walter Reinisch; Simon Travis; Stephen Hanauer; Hong Wang; Nawar Shara; M Scott Harris
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

8.  Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.

Authors:  David Tougeron; Guillaume Savoye; Céline Savoye-Collet; Edith Koning; Francis Michot; Eric Lerebours
Journal:  Dig Dis Sci       Date:  2008-11-12       Impact factor: 3.199

Review 9.  The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?

Authors:  Vivek Chhaya; Richard Pollok
Journal:  F1000Prime Rep       Date:  2013-11-01

10.  MRI characteristics of proctitis in Crohn's disease on perianal MRI.

Authors:  Charlotte J Tutein Nolthenius; Shandra Bipat; Banafsche Mearadji; Anje M Spijkerboer; Cyriel Y Ponsioen; Alexander D Montauban van Swijndregt; Jaap Stoker
Journal:  Abdom Radiol (NY)       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.